SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens

Abstract Background Current evidence on the risk of admission- or medication-requiring psychiatric sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is limited to selected populations, short durations, and loss to follow-up. This study examined if SARS-CoV-2 infect...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Valdemar Rømer, Pradeesh Sivapalan, Josefin Eklöf, Susanne D. Nielsen, Zitta B. Harboe, Tor Biering-Sørensen, Theis Itenov, Jens-Ulrik S. Jensen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Cambridge University Press 2023-01-01
coleção:	European Psychiatry
Assuntos:	Long COVID psychiatry psychopharmaceuticals SARS-CoV-2
Acesso em linha:	https://www.cambridge.org/core/product/identifier/S0924933823024185/type/journal_article
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!